The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ethyl 3-(4-chloro-3-sulfamoylbenzamido)-7-methylpyrazolo[1,5-a]pyrimidine-6-carboxylate ID: ALA4849958
PubChem CID: 164616133
Max Phase: Preclinical
Molecular Formula: C17H16ClN5O5S
Molecular Weight: 437.87
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)c1cnc2c(NC(=O)c3ccc(Cl)c(S(N)(=O)=O)c3)cnn2c1C
Standard InChI: InChI=1S/C17H16ClN5O5S/c1-3-28-17(25)11-7-20-15-13(8-21-23(15)9(11)2)22-16(24)10-4-5-12(18)14(6-10)29(19,26)27/h4-8H,3H2,1-2H3,(H,22,24)(H2,19,26,27)
Standard InChI Key: XQQVQQFTYJPMFE-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
9.2821 -17.7430 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0716 -18.5354 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.8632 -18.3215 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7310 -14.6352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7310 -15.4523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4363 -15.8568 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4363 -14.2224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1416 -14.6352 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1415 -15.4534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9197 -15.7063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4007 -15.0443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9198 -14.3824 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4363 -13.4052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0212 -14.2273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0188 -13.4101 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3147 -14.6379 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3099 -13.0035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3075 -12.1864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1722 -16.4835 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9715 -16.6535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2239 -17.4307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5183 -16.0462 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6743 -18.0350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9262 -18.8116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7263 -18.9822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2740 -18.3700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0192 -17.5958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3291 -19.3135 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9798 -19.7591 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
4 7 2 0
5 6 2 0
6 9 1 0
8 7 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 8 1 0
7 13 1 0
14 15 1 0
14 16 2 0
4 14 1 0
15 17 1 0
17 18 1 0
10 19 1 0
19 20 1 0
20 21 1 0
20 22 2 0
21 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 21 1 0
26 2 1 0
2 28 1 0
25 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 437.87Molecular Weight (Monoisotopic): 437.0561AlogP: 1.77#Rotatable Bonds: 5Polar Surface Area: 145.75Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.85CX Basic pKa: 0.60CX LogP: 1.51CX LogD: 1.50Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.58Np Likeness Score: -2.23
References 1. Gumus A, Bozdag M, Angeli A, Peat TS, Carta F, Supuran CT, Selleri S.. (2021) Privileged scaffolds in medicinal chemistry: Studies on pyrazolo[1,5-a]pyrimidines on sulfonamide containing Carbonic Anhydrase inhibitors., 49 [PMID:34371130 ] [10.1016/j.bmcl.2021.128309 ]